Burlingame, CA, United States of America

John A Flygare

This inventor holds 55 USPTO granted patents and 19 published patent applications, plus 10 CIPO patents and 22 EPO patents, primarily in Antibody-Drug Conjugates (CPC class A61K). Top assignees: Genentech, Inc., Tularik Limited, Medimmune Limited. Active years: 1999-2024.

USPTO Granted Patents = 55 (Patent Applications = 19)

% Patents Active = 74.5

CIPO Patents = 10 (Patent Applications = 11)

EPO Patents = 22 (Patent Applications = 30)

Average Co-Inventor Count = 5.8

ph-index = 15

Forward Citations = 773(Granted Patents)

Forward Citations (Not Self Cited) = 711(Dec 10, 2025)

Inventors with similar research interests:

Location History:

South San Francisco, CA (US) (2017 - 2023)
Burlingame, CA (US) (1999 - 2024)

Company Filing History:

Walter and Eliza Hall Institute of Medical Research

patents

5. 2 out of 4,186

Abbott Laboratories Corporation

Nerviano Medical Sciences S.r.l.

patents

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

Areas of Expertise:

Antibody-Drug Conjugates

IAP Inhibitors

Pyrrolobenzodiazepines

Peptidomimetic Compounds

Anthracycline Derivatives

Quaternary Amine Compounds

Heterocyclic Compounds

Arylsulfonamide Compounds

Azabicyclo-Octane Inhibitors

Dimer Compounds

Anti-Wall Teichoic Antibodies

Compounds and Methods

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11963994 - Inhibitors of IAP (2024-04-23),

2. 11692043 - Peptidomimetic compounds and antibody-drug conjugates thereof (2023-07-04),

3. 11135303 - Pyrrolobenzodiazepines and conjugates thereof (2021-10-05),

4. 11104673 - Quaternary amine compounds and antibody-drug conjugates thereof (2021-08-31),

5. 11096982 - Inhibitors of IAP (2021-08-24),

6. 11090322 - Anthracycline disulfide intermediates, antibody-drug conjugates and methods (2021-08-17),

7. 10632210 - Peptidomimetic compounds and antibody-drug conjugates thereof (2020-04-28),

8. 10576164 - Pyrrolobenzodiazepines and conjugates thereof (2020-03-03),

9. 10570192 - Anti-wall teichoic antibodies and conjugates (2020-02-25),

10. 10556895 - Quaternary amine compounds and antibody-drug conjugates thereof (2020-02-11),

11. 10544215 - 1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment (2020-01-28),

12. 10533058 - Peptidomimetic compounds and antibody-drug conjugates thereof (2020-01-14),

13. 10442836 - 1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment (2019-10-15),

14. 10149913 - Anthracycline disulfide intermediates, antibody-drug conjugates and methods (2018-12-11),

15. 10124069 - Peptidomimetic compounds and antibody-drug conjugates thereof (2018-11-13),

Title: The Innovative Journey of John A Flygare

Introduction: John A Flygare, a talented inventor based in Burlingame, CA, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: John A Flygare holds several patents in various technological domains, showcasing his versatility and creativity in innovation.

Career Highlights: With a career spanning over two decades, John A Flygare has consistently pushed the boundaries of technology through his inventive solutions. His work has been recognized for its impact on improving efficiency and functionality in different industries.

Collaborations: Throughout his career, John A Flygare has collaborated with leading tech companies and research institutions to bring his ideas to life. These partnerships have been instrumental in turning his innovative concepts into tangible products that benefit society.

Conclusion: John A Flygare's passion for innovation and his dedication to creating solutions that make a difference have solidified his reputation as a respected inventor in Burlingame, CA. His continued pursuit of excellence promises a future filled with groundbreaking inventions that will shape the technological landscape.